drugset / Trial / NCT00563927
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Unknown
340 enrolled
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To test the therapeutic ratio of additional chemotheray on advanced nasopharyngeal carcinoma.
Timeline
- Start
- 1999-03
- Primary completion
- —
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | fluorouracil | Small molecule | — | — |